22 hours ago
8
ARTICLE AD BOX
More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications. However, new research from Stanford Medicine and international collaborators suggests these drugs may be less effective for some individuals due to genetic differences.
About 10% of the population carries certain genetic variants linked to a newly identified phenomenon called GLP-1 resistance. In these individuals, levels of the hormone GLP-...
English (US) ·